Furthermore, we carried out survival analysis on 182 HCC patients using the GEPIA2 database, which demonstrated that heightened BPTF expression is associated with inferior disease-free survival in HCC patients (Figure S1C). The gene discussed is BPTF; the disease is hepatocellular carcinoma.